KMDA
Kamada Ltd. NASDAQ$8.29
Mkt Cap $478.2M
52w Low $6.50
62.8% of range
52w High $9.35
50d MA $8.54
200d MA $7.60
P/E (TTM)
21.6x
EV/EBITDA
7.7x
P/B
1.8x
Debt/Equity
0.0x
ROE
—
P/FCF
24.0x
RSI (14)
—
ATR (14)
—
Beta
0.31
50d MA
$8.54
200d MA
$7.60
Avg Volume
66.7K
About
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunizatio…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | AMC | 0.09 | 0.06 | -33.3% | 8.55 | -1.4% | +1.6% | +1.8% | +4.1% | +4.0% | +0.5% | — |
| Nov 10, 2025 | AMC | 0.10 | 0.09 | -10.0% | 7.02 | +1.6% | +0.6% | +3.7% | +0.9% | -0.4% | -2.6% | — |
| Aug 13, 2025 | AMC | 0.09 | 0.13 | +44.4% | 7.38 | -0.4% | -1.1% | -0.4% | -2.8% | -1.9% | -5.6% | — |
| May 14, 2025 | AMC | 0.07 | 0.07 | +0.0% | 7.05 | +0.0% | -2.7% | -1.6% | -3.3% | -2.6% | -3.1% | — |
| Mar 5, 2025 | AMC | 0.05 | 0.07 | +40.0% | 7.10 | +0.1% | +3.1% | +4.4% | -0.3% | +0.3% | +3.4% | — |
| Nov 13, 2024 | AMC | 0.07 | 0.07 | +0.0% | 6.03 | +0.0% | -2.8% | -3.6% | -1.3% | -2.0% | -3.5% | — |
| Aug 14, 2024 | AMC | 0.06 | 0.08 | +33.3% | 5.33 | +0.9% | +0.8% | +3.9% | +6.6% | +5.4% | +3.9% | — |
| May 8, 2024 | AMC | 0.06 | 0.04 | -33.3% | 5.74 | -2.3% | -3.1% | -3.5% | -3.0% | -1.4% | -2.6% | — |
| Mar 6, 2024 | AMC | 0.05 | 0.09 | +80.0% | 6.05 | +0.0% | +2.5% | +0.0% | -5.6% | -4.3% | -5.5% | — |
| Nov 13, 2023 | AMC | 0.03 | 0.06 | +100.0% | 4.79 | +0.2% | +1.5% | -3.5% | -1.3% | -1.5% | -1.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.73 | $6.78 | +0.7% | +1.2% | +4.5% | +4.3% | +4.3% | +7.7% |
| May 15 | Benchmark | Maintains | Buy → Buy | — | $7.05 | $7.05 | +0.0% | -2.7% | -1.6% | -3.3% | -2.6% | -3.1% |
| Mar 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.10 | $7.11 | +0.1% | +3.1% | +4.4% | -0.3% | +0.3% | +3.4% |
| Jan 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.32 | $7.83 | +7.0% | +1.2% | -1.6% | -1.5% | -1.1% | -3.1% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.03 | $6.03 | +0.0% | -2.8% | -3.6% | -1.3% | -2.0% | -3.5% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.33 | $5.38 | +0.9% | +0.8% | +3.9% | +6.6% | +5.4% | +3.9% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.74 | $5.61 | -2.3% | -3.1% | -3.5% | -3.0% | -1.4% | -2.6% |
| Mar 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.05 | $6.05 | +0.0% | +2.5% | +0.0% | -5.6% | -4.3% | -5.5% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.79 | $4.80 | +0.2% | +1.5% | -3.5% | -1.3% | -1.5% | -1.5% |
| Aug 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.31 | $5.65 | +6.4% | +9.8% | +9.4% | +5.1% | +2.8% | +2.3% |
Data updated apr 25, 2026 5:39pm
· Source: massive.com